(Q36080258)

12 August 2017

Detection of the anti-p53 antibody response in malignant and benign pancreatic disease (English)

1 reference

12 August 2017

Marxsen J

1

1 reference

12 August 2017

Schmiegel W

2

1 reference

12 August 2017

Röder C

3

1 reference

12 August 2017

Harder R

4

1 reference

12 August 2017

Juhl H

5

1 reference

12 August 2017

Henne-Bruns D

6

1 reference

12 August 2017

Kremer B

7

1 reference

12 August 2017

Kalthoff H

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 November 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

5

1 reference

12 August 2017

1031-1034

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.443

12 August 2017

0 references

cites work

Pancreatic adenocarcinomas frequently show p53 gene mutations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Clinical implications of the p53 tumor-suppressor gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

The p53 tumour suppressor gene

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

p53 mutations in human cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

p53 function and dysfunction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

TP53 tumor suppressor gene: a model for investigating human mutagenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Antibodies to the p53 tumor suppressor gene product quantified in cancer patient serum with a time-resolved immunofluorometric technique

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033558

p53 and K-RAS alterations in pancreatic epithelial cell lesions

23 September 2018

1 reference

12 December 2020

A death in the life of p53

1 reference

12 December 2020

p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis

1 reference

12 December 2020

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status

1 reference

12 December 2020

The cellular protein p53 in human tumours

1 reference

12 December 2020

Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma

1 reference

12 December 2020

Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.443

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

1 reference